Dual immunotherapy shows promise to treat recurrent or metastatic nasopharyngeal cancer
by SingHealthDetails on patient response and outcome data.aExtent and depth of response in trial cohort showing best tumor scan (Top) and changes in tumor size over time (Bottom). Not eval
Updated on: January 04,2024
9

Dual immunotherapy shows promise to treat recurrent or metastatic nasopharyngeal cancer
by SingHealthDetails on patient response and outcome data.aExtent and depth of response in trial cohort showing best tumor scan (Top) and changes in tumor size over time (Bottom). Not eval
Updated on:January 04,2024
9
